SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: seminole who wrote (1093)8/17/1998 10:31:00 AM
From: David Cathcart  Read Replies (1) of 1826
 
For those who do not follow the MOGN thread on Yahoo, the NCI has now listed two of their MGI 114 trials on their web-site.

Here is the site for the NCI sponsored phase II trial for MGI 114 in advanced renal cell carcinoma:

cancernet.nci.nih.gov

Here is the site covering the NCI sponsored phase I trial for pediatric patients with recurrent or refractory solid tumors:

cancernet.nci.nih.gov

More NCI sponsored trials are due to begin soon.

MGI Pharma has not made an announcement regarding the beginning of the NCI sponsored trials. This could mean that they are still only enrolling patients in the subject trials and that actual dosing has not begun yet. Or, MGI Pharma is simply choosing to be low key about the event. Whatever the case, it is good to see that the NCI is beginning to foot much of the bill to see if tiny MGI Pharma has a big cancer drug on its hands.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News